from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: HERON THERAPEUTICS, INC. /DE/ quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
HERON THERAPEUTICS, INC. /DE/ Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $414,999,000, a 0.98% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$414,999,000	-$4,109,000	-0.98%	31 Dec 2025	10-K	26 Feb 2026	2025	FY
Q4 2024	$419,108,000	-$10,656,000	-2.5%	31 Dec 2024	10-K	26 Feb 2026	2025	FY
Q4 2023	$429,764,000	+$6,960,000	+1.6%	31 Dec 2023	10-K	27 Feb 2025	2024	FY
Q4 2022	$422,804,000	+$45,387,000	+12%	31 Dec 2022	10-K	12 Mar 2024	2023	FY
Q4 2021	$377,417,000	+$51,459,000	+16%	31 Dec 2021	10-K	29 Mar 2023	2022	FY
Q4 2020	$325,958,000	+$53,619,000	+20%	31 Dec 2020	10-K	28 Feb 2022	2021	FY
Q4 2019	$272,339,000	+$49,480,000	+22%	31 Dec 2019	10-K	24 Feb 2021	2020	FY
Q4 2018	$222,859,000	+$50,728,000	+29%	31 Dec 2018	10-K	02 Mar 2020	2019	FY
Q4 2017	$172,131,000	+$3,241,000	+1.9%	31 Dec 2017	10-K	22 Feb 2019	2018	FY
Q4 2016	$168,890,000	+$55,173,000	+49%	31 Dec 2016	10-K	27 Feb 2018	2017	FY
Q4 2015	$113,717,000	+$40,445,000	+55%	31 Dec 2015	10-K	23 Feb 2017	2016	FY
Q4 2014	$73,272,000	+$32,035,000	+78%	31 Dec 2014	10-K	19 Feb 2016	2015	FY
Q4 2013	$41,237,000	+$22,037,000	+115%	31 Dec 2013	10-K	13 Mar 2015	2014	FY
Q4 2012	$19,200,000	+$8,900,000	+86%	31 Dec 2012	10-K	07 Mar 2014	2013	FY
Q4 2011	$10,300,000			31 Dec 2011	10-K	07 Mar 2014	2013	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.